
--- Page 1 ---
UUID:25F791D8-27D6-4DC6-8D96-505CF68A5F13 FINAL DIAGNOSIS: TCGA-BH-A42U-01A-PR Redacted Part 1:  Axilla, right, sentinel Lymph node #1 -- Colioction Dete:  One lymph node negative for metastatic tumor (0/1). Part 2:  AxIlLA, Right, Sentinel Lymph node #2 --  TWo Lymph noDes negative For metastatic tumOr (0/2). Part 3: AxIlLA, Right, non-Sentinel Lymph node -- Two Lymph noDes negatve For metastatic tumor (0/2). PArT 4: BREAST, RiGHT, TOTAL. MAStECTOMY - A. iINFILTraTING LoBuLAR CArcinomA, nOTTIngham SCORe 6/9 (tUBuLe fOrmaTiOn = 3, nUCLeAR GRADE = 2, MITOSIS = 1), 3.0 X 2.8 X 2.5 CM. S0e comment. B. NiPPLE WITH PeRIDUCTAL inFLAmMATION ANd FIBrOCySTIC ChAngeS. NO TUmOR SEeN! C TUmOr iNFILTrAteS StrIateD muSCLe FiBERS Of THe POsteriOR  MArgin, BuT The mArgin IS FREE OF TUMOR. D.  ALL SUrgIcal Lines Of ReSecTIOn Are frEE OF TuNOR. E. NO VASCULAR LYMPHATIC SPACE INVASION NOTED. Part 5: AxiLlA, Right, sentinel Lymph node #4 -- ANe Lymph nOde negative for metA8tATic tumOr (0/1) COMmenT: The diagnsosls of lobular carcinoma is confirmed with a negatve E-Cadherin immunostain.. MICROSCOPIC: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST A. Laterality: 1. Right 2. Left B. Procedure:3 1. Segmentectomy 2. Simple mastectomy 3. Modified radical mastectomy 4. Ra-excislon C. Location: 2 1. Central subareolar 2. u0Q 4.L0Q 3. UIQ 5. LIQ 6. Not specified 3.0 cm E. Tumor Multifocal: 2 1. Yes 2. No F. Largest Diameter: 3 cm G. Aggregate Dianeter:3 cm H. Type(s) (invasive component): 7 1. Ductal, NOS 7. Lobutar 2. Tubular 3. Mucinous 8. Carcinold tike 4. Medullary 9. Metapiastic 10.Other 5. Cribriform 6. Papillary I. If obular carcinoma, specity type: 1. Classical 4. Signet ring 2. Solld 3. Alveolar 5. Trabecular 6. Plaomorphic. lobular carcinoma, histiocytic type J. Nottingham Score:  J1. Nuclear grade: J2. Tubule formation: 3 2 J3. Mitotic activity score: J4. Total Nottingham score: .6 J5. Nottingham grade (1. 2, 3): K. Lympho-Vascular Invasion: 1. Ye8 2. No L. Dermal lymphatic invasion: NA 1. Yes 2. No 3. Not applicable M. Calcification: 3 1.Yes benign zones 2. Yes mallgnant zones 3.No 1cD.0-3 carcinoma,inFi Itrating 1Obuiar,NOS 952Pj3 Sik: breast,Nos g1i2pp CI4

--- Page 2 ---
NI. uuIs: 1. Yes 2. No N2. Type of in situ component:. 1. Cribriform N/A 2. Solld 4. Micropapillary 3. Papillary 5. Apocrine 6. Comedo 7. Lobular N3. Percentage of tumor occupiod by in situ component:0%  O1. Surgical margins involved by invasive component:3 1.Yes  focal 2. Yes diffuse 3.No Q2. Distance from Margin: 1 mm O3. Which margin: 1. Superlor 2. Inferior 3. Antertor 4. Poslerior 5. Lateral 3. Medial P1. Surgical margins involved by in situ component:NA 1.Yes focal 2. Yes- diffuse 3. No P2. Distance from Margin: NA P3.Which margin: 4 1. Superor 2. Inferlor 3. Anterior 4. Posterior 5. Lateral 6. Medlal Q. Paget's disease of nipple:2. 1.Yes 2. No R. Number of positive lymph nodes: S. Total number of lymph nodes examined: T. Sentinel node metastasis: 2 1. Yes 2. No U. Only micromctastases to lymph nodes (<0.2 cm):  NA 1. Yes 2. No V. Matastasis/es to a iymph node (>0.2 cm) or more in greatest dimension: 1. Yes NA 2. No W. Lymph node metastasis/es with extracapsular extension:N/A 1. Yes 2. No X. Metastases to ipsilateral intemal mammary lymph node (if appticable):N/A 1. Yes 2. No Y. Skin invotived (ulceratlon): 1.Yes 2 2. No Z. Non-neoplastic breast tissue:. 1. ADH 4. Flbroadenoma 2. ALH 5, Papilloma 3. Radical scar 6. FCD 7.LCIS 8. Other AA. Multicentricity/muttifocality of invasive focil: 1. Yes 2. No BB. TNM stage: t 2n0m X CC. Immunohistochemistry of hormane receptors and target receptors JJ1. ER 1: Posiive JJ2. PR 1: Positive JJ3. Her2/Neu 2: Negative.